PharmaJet
PrivateLast Round
Series H
Oct 13, 2023
Total Funding Raised
$103.89M
Company Overview
PharmaJet is a medical equipment manufacturing company that develops needle-free precision delivery systems designed to provide a standard of care in the vaccine delivery market.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmaJet Comparables
Compare PharmaJet with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micron Biomedical | 86% | |
| Vaxxas | 83% | |
| Portal Instruments | 83% | |
PharmaJet Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series H | Oct 13, 2023 | ||||
| Grant | Nov 29, 2022 | ||||
| Grant | Oct 24, 2022 | ||||
| Series G | Apr 13, 2021 | ||||
| Convertible Debt | Jun 10, 2020 | ||||
Grant | Mar 17, 2020 |
PharmaJet Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stout Street Capital | Series F |
| USAID | Grant |
| MedTech Innovator | Series F |
| NIH RADx | Grant |
| 3Lines Venture Capital | Series F |
| Rockies Venture Club | Convertible Debt, Series E, Series H, Series F, Series G, Growth Equity |
| Defense Threat Reduction Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
Presenting at the 15th Annual PODD conference in Boston on Oct 27-28, 2025.
- Jul 10, 2025
Will provide needle-free delivery technology for routine immunizations in Egypt.
PharmaJet Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |